This may be due to following reasons: (1) most of these study didn't aim to evaluate the effect of insulin sensitivity or β-cell function, thus generated some confounding factors, such as different treatment on diabetes; (2) different intervention methods in studies, such as different kinds or dosage of uric acid-lowering agents; (3) sample size was not large enough. This evidence concerns the gene INS and diabetes mellitus.